These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31534811)

  • 1. Vigabatrin-Induced Encephalopathy in a 5.5-Month-Old Girl with Infantile Spasms due to Tuberous Sclerosis.
    Klinaki E; Argyri I; Amountza G; Ioannidou G; Maritsi D; Garoufi A; Vartzelis G
    Case Rep Pediatr; 2019; 2019():7249237. PubMed ID: 31534811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
    Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
    Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.
    Hancock E; Osborne JP
    J Child Neurol; 1999 Feb; 14(2):71-4. PubMed ID: 10073425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study.
    Vigevano F; Cilio MR
    Epilepsia; 1997 Dec; 38(12):1270-4. PubMed ID: 9578521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of vigabatrin for the treatment of infantile spasms.
    Faulkner MA; Tolman JA
    J Cent Nerv Syst Dis; 2011; 3():199-207. PubMed ID: 23861649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis.
    Chiron C; Dumas C; Jambaqué I; Mumford J; Dulac O
    Epilepsy Res; 1997 Jan; 26(2):389-95. PubMed ID: 9095401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin for infantile spasms.
    Pesaturo KA; Spooner LM; Belliveau P
    Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Initial Treatment for Infantile Spasms in a Contemporary US Cohort.
    Grinspan ZM; Knupp KG; Patel AD; Yozawitz EG; Wusthoff CJ; Wirrell EC; Valencia I; Singhal NS; Nordli DR; Mytinger JR; Mitchell WG; Keator CG; Loddenkemper T; Hussain SA; Harini C; Gaillard WD; Fernandez IS; Coryell J; Chu CJ; Berg AT; Shellhaas RA
    Neurology; 2021 Sep; 97(12):e1217-e1228. PubMed ID: 34266919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R
    Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of patients with infantile spasms.
    Mikati MA; Lepejian GA; Holmes GL
    Clin Neuropharmacol; 2002; 25(2):61-70. PubMed ID: 11981230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epileptic spasms in tuberous sclerosis complex.
    Hsieh DT; Jennesson MM; Thiele EA
    Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin monotherapy for infantile spasms.
    Gaily E
    Expert Rev Neurother; 2012 Mar; 12(3):275-86. PubMed ID: 22364326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.
    Jambaqué I; Chiron C; Dumas C; Mumford J; Dulac O
    Epilepsy Res; 2000 Feb; 38(2-3):151-60. PubMed ID: 10642043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocorticotropic hormone and vigabatrin treatment of children with infantile spasms underlying cerebral palsy.
    Zafeiriou DI; Kontopoulos EE; Tsikoulas IG
    Brain Dev; 1996; 18(6):450-2. PubMed ID: 8980841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
    O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of vigabatrin in patients with infantile spasms.
    Elterman RD; Shields WD; Mansfield KA; Nakagawa J;
    Neurology; 2001 Oct; 57(8):1416-21. PubMed ID: 11673582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infantile spasms.
    Hancock EC; Osborne JP; Edwards SW
    Cochrane Database Syst Rev; 2008 Oct; (4):CD001770. PubMed ID: 18843624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocorticotropic hormone versus prednisolone in the treatment of infantile spasms post vigabatrin failure.
    Jones K; Snead OC; Boyd J; Go C
    J Child Neurol; 2015 Apr; 30(5):595-600. PubMed ID: 24965788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocorticotropic hormone for the treatment of West Syndrome in children.
    Shumiloff NA; Lam WM; Manasco KB
    Ann Pharmacother; 2013 May; 47(5):744-54. PubMed ID: 23606552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
    Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
    J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.